This is read by an automated voice. Please report any issues or inconsistencies here. Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and ...
Creative Biolabs has upgraded its mRNA technology platform to provide integrated solutions for therapeutic development and induced pluripotent stem cell reprogramming, accelerating advancements in ...
Department of Biomedical Sciences, Graduate School, Korea University, Seoul 02707, Republic of Korea BK21 Graduate Program, Department of Biomedical Sciences, Korea University College of Medicine, ...
PHOENIX, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage leader in regenerative and cellular ...
Metabolic reprogramming in fibrotic lung diseases involves key metabolites like lactate, succinate, and 2-hydroxyglutarate, driving inflammation and fibroblast activation. Lactate accumulation ...
Exosomes are extracellular vesicles 30 to 150 nm in size, mediating the paracrine effects of mesenchymal stem cells (MSCs) and induced pluripotent stem cell–derived cardiomyocytes (iCMs) when used to ...
Hosted on MSN
Can We Reprogram Our DNA? The Future of Genetics
The cost of sequencing DNA has dropped dramatically, and with technologies like CRISPR, gene editing is becoming more precise and powerful than ever. From curing genetic diseases to designing the next ...
Hosted on MSN
The Promise and Perils of Reprogramming Immunity
Scientists are reprogramming the immune system through cutting-edge approaches like CAR-T cells, engineered dendritic vaccines, AI-driven antibody design, and senolytic therapies, highlighting both ...
Glucocorticoids represent the most potent class of anti-inflammatory drugs. However, their anti-inflammatory mode of action has been incompletely understood. Recent insights have revealed a key role ...
Researchers have uncovered how metabolic reprogramming contributes to renal fibrosis in IgG4-related disease (IgG4-RD), a systemic immune-mediated disorder. The review, published in a leading journal, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results